Concepedia
Statistics
Publications
4
Citations
687
H-Index
Active since
2003
Affiliations
Novartis (Switzerland)(Current)
Centre hospitalier universitaire de Québec
University of Auckland
Nottingham City Hospital
Novartis (United States)
Judy Pak is an author at Novartis (Switzerland) specializing in pharmacotherapy, bone metabolism pharmacotherapy, and bone augmentation.
Publications per year
2003–2017
Comparison of a Single Infusion of Zoledronic Acid with Risedronate for Paget's Disease
Ian R. Reid, Paul D. Miller, Kenneth W. Lyles et al. · New England Journal of Medicine · 2005 · 434 citations · Full text
Pharmacy, Pharmacotherapy, Bone Augmentation +3
Long-Term Control of Bone Turnover in Paget's Disease With Zoledronic Acid and Risedronate
David Hosking, Kenneth W. Lyles, Jacques P. Brown et al. · Journal of Bone and Mineral Research · 2006 · 160 citations · Full text
Medicine, Pharmacotherapy, Bone Augmentation +16
Serelaxin as a potential treatment for renal dysfunction in cirrhosis: Preclinical evaluation and results of a randomized phase 2 trial
Victoria Snowdon, Neil Lachlan, Anna M. Hoy et al. · PLoS Medicine · 2017 · 65 citations · Full text
Medicine, Pharmacology, Pharmacotherapy +16
Differences in embryonic development in sensitive and resistant matings to pregnancy block stimuli in mice
Hye Jin Chung, Judy Pak, BK Kim et al. · Reproduction · 2003 · 28 citations
Life Sciences, Animal Sciences, Developmental Biology +15
1–4 of 4